http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020508671-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y103-01 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-61 |
| filingDate | 2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020508671-A |
| titleOfInvention | Recombinant Escherichia coli producing equol derivatives and method for synthesizing equol derivatives using the same |
| abstract | The present invention Surakkia iso Flavobacterium Nikon barman scan (Slackia isoflavoniconvertens) derived enzyme (daidzein reductase, dihydrodaidzein racemase, dihydrodaidzein reductase, tetrahydrodaidzein reductase) using a recombinant E. coli expressing a, from daidzein or genistein (genistein), equol , Dihydroequol, 5-hydroxy-equol (5-hydroxy-equol) and 5-hydroxy-dehydroequol (5-hydroxy-dehydroequol). The biotransformation composition expressing the microorganism strain and 5-hydroxy-equol or 5-hydroxy-dihydroequol can be used as an antioxidant, an anticancer agent, etc., for preventing or treating climacteric diseases. Can be used. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114806999-A |
| priorityDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.